Literature DB >> 26745070

Upregulation of Mir-34a in AGS Gastric Cancer Cells by a PLGA-PEG-PLGA Chrysin Nano Formulation.

Farideh Mohammadian1, Alireza Abhari, Hassan Dariushnejad, Faraz Zarghami, Alireza Nikanfar, Yones Pilehvar-Soltanahmadi, Nosratollah Zarghami.   

Abstract

BACKGROUND: Nano-therapy has the potential to revolutionize cancer therapy. Chrysin, a natural flavonoid, was recently recognized as having important biological roles in chemical defenses and nitrogen fixation, with anti-inflammatory and anti-oxidant effects but the poor water solubility of flavonoids limitstheir bioavailability and biomedical applications.
OBJECTIVE: Chrysin loaded PLGA-PEG-PLGA was assessed for improvement of solubility, drug tolerance and adverse effects and accumulation in a gastric cancer cell line (AGS).
MATERIALS AND METHODS: Chrysin loaded PLGA-PEG copolymers were prepared using the double emulsion method (W/O/W). The morphology and size distributions of the prepared PLGA-PEG nanospheres were investigated by 1H NMR, FT-IR and SEM. The in vitro cytotoxicity of pure and nano-chrysin was tested by MTT assay and miR-34a was measured by real-time PCR.
RESULTS: 1H NMR, FT-IR and SEM confirmed the PLGA-PEG structure and chrysin loaded on nanoparticles. The MTT results for different concentrations of chrysin at different times for the treatment of AGS cell line showed IC50 values of 68.2, 56.2 and 42.3 μM and 58.2, 44.2, 36.8 μM after 24, 48, and 72 hours of treatment, respectively for chrysin itslef and chrysin-loaded nanoparticles. The results of real time PCR showed that expression of miR-34a was upregulated to a greater extent via nano chrysin rather than free chrysin.
CONCLUSIONS: Our study demonstrates chrysin loaded PLGA-PEG promises a natural and efficient system for anticancer drug delivery to fight gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26745070     DOI: 10.7314/apjcp.2015.16.18.8259

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

1.  Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.

Authors:  Arman Shahabi; Behrooz Naghili; Khalil Ansarin; Maryam Montazeri; Mehdi Dadashpour; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

Review 2.  Update on biomaterials for prevention of epidural adhesion after lumbar laminectomy.

Authors:  Huailan Wang; Wenjia Sun; Dongliang Fu; Yueliang Shen; Ying-Ying Chen; Lin-Lin Wang
Journal:  J Orthop Translat       Date:  2018-03-07       Impact factor: 5.191

3.  Improved chemotherapeutic efficacy of injectable chrysin encapsulated by copolymer nanoparticles.

Authors:  Kyoung Mee Kim; Hyun Kyung Lim; Sang Hee Shim; Joohee Jung
Journal:  Int J Nanomedicine       Date:  2017-03-09

Review 4.  Research Progress in microRNA-Based Therapy for Gastric Cancer.

Authors:  Xu Zhao; Gao-Feng Hu; Yan-Fen Shi; Wei Xu
Journal:  Onco Targets Ther       Date:  2019-12-24       Impact factor: 4.147

5.  Antineoplastic Activity of Chrysin against Human Hepatocellular Carcinoma: New Insight on GPC3/SULF2 Axis and lncRNA-AF085935 Expression.

Authors:  Iman O Sherif; Laila A Al-Mutabagani; Dina Sabry; Nehal M Elsherbiny
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

6.  Omics Integration Analysis Unravel the Landscape of Driving Mechanisms of Colorectal Cancer.

Authors:  Fatemeh Nikmanesh; Shamim Sarhadi; Mehdi Dadashpour; Yazdan Asghari; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01

7.  Evaluation of the Hemocompatibility and Anticancer Potential of Poly(ε-Caprolactone) and Poly(3-Hydroxybutyrate) Microcarriers with Encapsulated Chrysin.

Authors:  Eleftherios Halevas; Chrysoula Kokotidou; Elda Zaimai; Alexandra Moschona; Efstratios Lialiaris; Anna Mitraki; Theodore Lialiaris; Anastasia Pantazaki
Journal:  Pharmaceutics       Date:  2021-01-16       Impact factor: 6.321

8.  Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression

Authors:  Sara Rasouli; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-25

9.  In-vitro Transcribed mRNA Delivery Using PLGA/PEI Nanoparticles into Human Monocyte-derived Dendritic Cells.

Authors:  Zarin Sharifnia; Mojgan Bandehpour; Hamed Hamishehkar; Nariman Mosaffa; Bahram Kazemi; Nosratollah Zarghami
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

Review 10.  The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.

Authors:  Jiulue Hu; Jelena Stojanović; Saman Yasamineh; Pooneh Yasamineh; Sathish Kumar Karuppannan; Mohammed Junaid Hussain Dowlath; Hamed Serati-Nouri
Journal:  Arch Virol       Date:  2021-07-19       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.